Additional file 2 of Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy

Additional file 2: Table S1. Association of changes in pVO2 with baseline factors. Table S2. Individual metabolites and their association with pVO2. Table S3. Association of individual metabolites and time to primary clinical outcome (multivariate model). Table S4. Association of individual metabolites and all-cause mortality (time to event, multivariate model) in CATHGEN. Table S5. Absolute baseline metabolite concentrations stratified by primary outcome of all-cause mortality or hospitalization.